S 3474119th CongressIn Committee
Cannabinoid Safety and Regulation Act
Standard Summary
Balanced plain-English summary
This Senate bill would amend the Federal Food, Drug, and Cosmetic Act to create an FDA regulatory framework for cannabis and cannabinoid products, including facility registration, product listing, labeling and misbranding rules, adulteration standards, public health surveillance, youth-use prevention, and cannabis-impaired driving research and grants.
Key Points
- 1Establishes FDA registration, product listing, labeling, and adulteration/misbranding requirements for cannabinoid products
- 2Creates public health surveillance and awards to prevent underage cannabis use
- 3Authorizes cannabis-impaired driving research, state grants, and a possible national impairment standard
- 4Appropriates funding for impaired driving prevention and related public health activities
Impact Areas
Cannabis and cannabinoid manufacturersRetailers and distributorsConsumersFDA and public health agenciesStates and highway safety programsDrivers
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026